Tag Archives: Allergy Med Singulair to Get Black Box Warning Over Psych Side Effects FDA

Allergy Med Singulair to Get ‘Black Box’ Warning Over Psych Side Effects: FDA

News Picture: Allergy Med Singulair to Get

WEDNESDAY, March 4, 2020 (HealthDay News) — Asthma and allergy drug montelukast — sold as a generic and under the brand name Singulair — will get a “boxed warning” over potential ties to neuropsychiatric effects, the U.S. Food and Drug Administration announced on Wednesday. The drug has long carried a …

Read More »